Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lehfeld, H.
Ihl, R.
Schweizer, A.
Steinwachs, K.
Frölich, L.
Gutzmann, H.
Blaha, L.
Kügler, C.
Steiner, I.
Jentzsch, J.
Schmidt, K.-H.
Fischer, W.
Kagerbauer, A.-M.
Bürger, G.
Autenrieth, T.
Heinrich, C.
Mösler, T.
Zimmermann, P.
Horn, R.
Kinzler, E.
Schubert, H.
Lehmann, E.
and
Erzigkeit, H.
1999.
Psychometrische Schweregradbeurteilung bei dementiellen Erkrankungen: Ein Vergleich von MMST, ADAS, BCRS und SKT.
Zeitschrift für Neuropsychologie,
Vol. 10,
Issue. 4,
p.
187.
Ihl, Ralf
1999.
Alzheimer Demenz.
p.
109.
Mundt, J. C.
Freed, D. M.
and
Greist, J. H.
2000.
Lay Person-Based Screening for Early Detection of Alzheimer's Disease: Development and Validation of an Instrument.
The Journals of Gerontology Series B: Psychological Sciences and Social Sciences,
Vol. 55,
Issue. 3,
p.
P163.
Perrault, Anne
Oremus, Mark
Demers, Louise
Vida, Stephen
and
Wolfson, Christina
2000.
Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Behavior and Mood Scales.
Journal of Geriatric Psychiatry and Neurology,
Vol. 13,
Issue. 4,
p.
181.
Lee, Michelle M.
Strauss, Milton E.
and
Dawson, Deborah V.
2000.
Changes in emotional and behavioral symptoms of Alzheimer's disease.
American Journal of Alzheimer's Disease,
Vol. 15,
Issue. 3,
p.
176.
Schultz, R.R.
Siviero, M.O.
and
Bertolucci, P.H.F.
2001.
The cognitive subscale of the "Alzheimer's Disease Assessment Scale" in a Brazilian sample.
Brazilian Journal of Medical and Biological Research,
Vol. 34,
Issue. 10,
p.
1295.
Youn, J. C.
Lee, D. Y.
Kim, K. W.
Lee, J. H.
Jhoo, J. H.
Lee, K. U.
Ha, J.
and
Woo, J. I.
2002.
Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS‐K).
International Journal of Geriatric Psychiatry,
Vol. 17,
Issue. 9,
p.
797.
Matthews, Brandy
Siemers, Eric R.
and
Mozley, P. David
2003.
Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease.
The American Journal of Geriatric Psychiatry,
Vol. 11,
Issue. 2,
p.
146.
Eid, Clark N.
Wu, Yong‐Jin
and
Kinney, Gene G.
2003.
Burger's Medicinal Chemistry and Drug Discovery.
p.
779.
Sevush, Steven
Peruyera, Gloria
Bertran, Annette
and
Cisneros, Wendy
2003.
A Three-Factor Model of Cognition in Alzheimer Disease.
Cognitive and Behavioral Neurology,
Vol. 16,
Issue. 2,
p.
110.
Blesa, Rafael
2004.
Noncognitive Symptoms and Long-Term Treatment Expectations for Alzheimer Disease.
Alzheimer Disease & Associated Disorders,
Vol. 18,
Issue. ,
p.
S9.
Orgogozo, J-M
Small, GW
Hammond, G
Van Baelen, B
and
Schwalen, S
2004.
Effects of galantamine in patients with mild Alzheimer's disease.
Current Medical Research and Opinion,
Vol. 20,
Issue. 11,
p.
1815.
Matza, L. S.
Buchanan, R.
Purdon, S.
Brewster-Jordan, J.
Zhao, Y.
and
Revicki, D. A.
2005.
Measuring Changes in Functional Status Among Patients With Schizophrenia: The Link With Cognitive Impairment.
Schizophrenia Bulletin,
Vol. 32,
Issue. 4,
p.
666.
Scott, I. A.
and
Greenberg, P. B.
2005.
Cautionary tales in the clinical interpretation of therapeutic trial reports.
Internal Medicine Journal,
Vol. 35,
Issue. 10,
p.
611.
Peskind, Elaine R.
Potkin, Steven G.
Pomara, Nunzio
Ott, Brian R.
Graham, Stephen M.
Olin, Jason T.
and
McDonald, Scott
2006.
Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial.
The American Journal of Geriatric Psychiatry,
Vol. 14,
Issue. 8,
p.
704.
Mavioglu, H.
Gedizlioglu, M.
Akyel, S.
Aslaner, T.
and
Eser, E.
2006.
The validity and reliability of the Turkish versii̇on of Alzheimer's Disease Assessment Scale‐Cognitive Subscale (ADAS‐Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
International Journal of Geriatric Psychiatry,
Vol. 21,
Issue. 3,
p.
259.
Pyo, Geunyeong
Elble, Rodger J
Ala, Thomas
and
Markwell, Stephen J
2006.
The Characteristics of Patients With Uncertain/Mild Cognitive Impairment on the Alzheimer Disease Assessment Scale-Cognitive Subscale.
Alzheimer Disease & Associated Disorders,
Vol. 20,
Issue. 1,
p.
16.
Fonteh, A. N.
Harrington, R. J.
Tsai, A.
Liao, P.
and
Harrington, M. G.
2007.
Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects.
Amino Acids,
Vol. 32,
Issue. 2,
p.
213.
Gregory, Tess
Nettelbeck, Ted
Howard, Sara
and
Wilson, Carlene
2008.
Inspection Time: A biomarker for cognitive decline.
Intelligence,
Vol. 36,
Issue. 6,
p.
664.
Mittelman, Mary Sherman
Brodaty, Henry
Wallen, Aaron Seth
and
Burns, Alistair
2008.
A Three-Country Randomized Controlled Trial of a Psychosocial Intervention for Caregivers Combined With Pharmacological Treatment for Patients With Alzheimer Disease: Effects on Caregiver Depression.
The American Journal of Geriatric Psychiatry,
Vol. 16,
Issue. 11,
p.
893.